What kills your deal before it starts – and what you can do about it
In this article: Nearly half of businesses that enter a sale process never close. Of those that do, many don't deliver the clean exit the founder expected – proceeds are deferred, contingent or structured in ways that leave the seller carrying risk. This article examines the valuation gap between what a founder believes the business is worth and what a buyer's diligence actually finds, why that gap is not cleanly closed during a process, and what founders can do – long before a buyer is involved – to build a business that holds up when someone who has never seen it takes it apart.
A transferable business is a healthy business
In this article: Most founders track output metrics – revenue, growth, profitability – that measure how a business produces. They don’t show whether it’s structurally sound. A profitable business and a healthy business are not the same. Transferability – the ability of a business to operate, perform and grow without its founder at the helm – is a more reliable measure of health than any standard KPI set. A business doesn’t need to be sold to benefit from being transferable; day to day, it runs cleaner, is more resilient and gives the founder more options.
The hidden ceiling: your leadership is the constraint you can’t see
In this article: The most common barrier to scaling founder-led businesses between $2m and $20m is not the market, product, team or capital structure. It’s the founder's own leadership – not because they lack talent or effort, but because leadership is the domain that sets the conditions for everything else. The problem presents as dysfunction in market, people, process, finance or technology, but the cause lives somewhere the founder is least equipped to examine: their own orientation, habits and decision-making patterns.
When closing isn’t the finish line: the deal that follows you home
In this article: Closing doesn't end a founder's financial exposure – it redefines it. More than half of lower-middle market transactions defer proceeds through earnouts, seller notes or rollover equity, making the money a founder expects to receive dependent on what happens inside a business they no longer control. This article examines how each structure works, what risk it transfers back to the seller, and why the business a founder builds before a process starts is the most effective protection against terms they didn't plan for.
Red flags your “healthy-growth” business is on borrowed time
In this article: A growing business with strong revenue and healthy margins can carry structural weaknesses that only become visible under a buyer’s scrutiny. Revenue concentration, founder-held client relationships, knowledge that lives in individuals, financials that only look backward and decision-making that routes through one person – these things don’t just erode value, they cap growth, concentrate risk and limit what the business can be, regardless of whether a transaction is ever on the table. Buyers are trained to find all five. Most founders aren't aware they even exist until they’re in a diligence process, the deal has closed but earnouts aren’t paying, or a key person leaves.
“I am the business” - why it works at $2m but kills you at $10m
In this article: Being the business can get you to $2m but starts working against you shortly after. Founder dependency isn’t a personal failing; it’s an essential part of a growing business. Left on its own, however, what can start as a competitive edge invariably turns into a structural condition that burns out the founder, undermines employees, and puts the business at risk. This article highlights three main areas where founder dependency can occur – bandwidth, capability and relationships – what that looks like, why it’s hard to see from the inside, and what the transition out of it requires.
What’s actually holding your business together
In this article: Only 1% of businesses reach $10m - $15m in revenue. Just 0.4% ever see $30m, and only 0.2% make it to $50m. The gap between the 1% and everyone else isn’t just product‑market fit. It’s whether the business has the architecture to hold together as pressure and complexity increase. This article maps the six domains that sit underneath every scalable, transferable business – People, Process, Finance, Technology, Leadership and Market – and shows what happens when any of them is underdeveloped or disconnected.
The Drop Test: will your business break?
In this article: The Drop Test reveals the operational health of a founder-led business by asking a single practical question: could a competent person walk into your business on Monday and keep it running? Not fix it, not improve it – run it. The test focuses on two levers: authority beyond the founder and whether the information needed to run the business is accessible. The answer often exposes more structural fragility than founders expect.
Don’t confuse profitability with transferability
In this article: A profitable business generates returns. A transferable business – one that can be handed to someone else to operate without degrading – generates returns and can sustain them without its current leadership. The two should not be confused. It is one of the most common – and costly – mistakes founders make, eroding the value of their asset and putting unnecessary strain on their time and personal lives. This article lays out the issues that most often keep founder-run businesses from being a valuable, transferable asset.
The four things that break when you scale
In this article: Scaling a business doesn't create new problems — it exposes structural ones that were already present but contained. This article names four specific breakdowns that occur predictably in founder-led businesses under growth pressure: decision authority that never moved beyond the founder, operational knowledge that was never codified, financial reporting that was never built for forward visibility, and a technology stack that was never designed as infrastructure. Understanding what’s behind each is the first step to addressing them before they compound.